Literature DB >> 11533696

Excitotoxic destruction facilitates brain tumor growth.

J D Rothstein, H Brem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11533696     DOI： 10.1038/nm0901-994

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

2.  Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth.

Authors:  Marie-Josée Beaudet; Naika Rueda; Gary P Kobinger; Jérôme Villeneuve; Luc Vallières
Journal:  J Neurooncol       Date:  2009-12-18       Impact factor: 4.130

3.  Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma.

Authors:  Rita Sattler; Betty Tyler; Benjamin Hoover; Luke T Coddington; Violette Recinos; Lee Hwang; Henry Brem; Jeffrey D Rothstein
Journal:  J Neurosurg       Date:  2013-08-02       Impact factor: 5.115

4.  Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.

Authors:  Kaleb Yohay; Betty Tyler; Kyle D Weaver; Andrea C Pardo; Dan Gincel; Jaishri Blakeley; Henry Brem; Jeffrey D Rothstein
Journal:  J Neurosurg       Date:  2014-01-31       Impact factor: 5.115

5.  Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.

Authors:  L Sleire; B S Skeie; I A Netland; H E Førde; E Dodoo; F Selheim; L Leiss; J I Heggdal; P-H Pedersen; J Wang; P Ø Enger
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

Review 6.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

Review 7.  Glutamate and its receptors in cancer.

Authors:  Andrzej Stepulak; Radoslaw Rola; Krzysztof Polberg; Chrysanthy Ikonomidou
Journal:  J Neural Transm (Vienna)       Date:  2014-03-09       Impact factor: 3.575
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.